The National Cancer Institute's Office of HIV and AIDS Malignancy (OHAM) hosted a virtual workshop on October 13th to discuss the possibility of developing a vaccine against Kaposi sarcoma-associated herpesvirus (KSHV).
The National Cancer Institute's Office of HIV and AIDS Malignancy (OHAM) hosted a virtual workshop on October 13th to discuss the possibility of developing a vaccine against Kaposi sarcoma-associated herpesvirus (KSHV).